PPT-Preventing Occupational Exposure to Hazardous Drugs

Consultation Education and Training Division Michigan Occupational Safety and Health Administration wwwmichigangovmiosha 5172847720 Module 1 Module 1 Training Overview Hazardous drug categories. Susan Ripple, MS, CIH, Fellow. Global Manager – Industrial Hygiene. The Dow Chemical Company. Midland, MI. Value of Occupational Exposure Bands (OEB) to supplement other authoritative OELs. Value of OEBs to the industrial hygiene process (ERAM). Consultation Education and Training Division. Michigan Occupational Safety and Health Administration . www.michigan.gov/miosha. 517-284-7720. Module 1. Module 1 Training Overview. Hazardous drug categories. Consultation Education and Training Division. Michigan Occupational Safety and Health Administration . www.michigan.gov/miosha. 517-284-7720. Module 2. Before Beginning Module 2. Please review . Module 1. Proposed Rule. October 20, 2015. SBEAP Technical Subcommittee. Outline of Today’s Briefing. 2. Part I: Background. Which Pharmaceuticals are Hazardous Waste?. Flow of Pharmaceuticals & Problem Areas. x0000x00001 x/MCIxD 0 x/MCIxD 0 x/MCIxD 1 x/MCIxD 1 For more information about the National Occupational Research Agenda NORA visit the web site https//wwwcdcgov/niosh/nora/For monthly updates on NO Guidelines and Approaches . Luvuyo Dzingwa . 21 April 2018. Introduction. 01. Effects of Occupational Lung Exposures. 02. Clinical Approach. 03. Social dimension. 04. Summary . 05. Outline. Introduction. HAS 222. Presentation Plan. Definition of occupational diseases. Epidemiological data on occupational diseases. Exposure routes for occupational diseases. Classification. of . occupational. . diseases. Drugs. CWT Clinical/Nursing Education . 2. Overview. Handling Hazardous Drugs in Healthcare Settings . United States Pharmacopeia, Chapter <800> . is a federally mandated regulation that broadens the definition of hazardous drugs and outlines safe practices for employees handling hazardous drugs.. EH&S Safety | 02/2018 Page 1 of 1 3 Chemotherap y and Other Hazardous Drugs Safe Use Guidelines I. Introduction II. Laboratory Planning and Preparation for Use III. Engineering Controls IV. Perso A PUBLICATI O PRIVATE PRACTICE SECTION 2018 CREDITS Scientific Editors Luke P. Lee, MD, MPH, CIME, MBA, CPA Chair, ACOEM Private Practice Section Douglas W. Martin MD, FACOEM, FAAFP, FIAIME Secretary/ the Recording and Noti cation of Occupational Accidents and Diseases The General Conference of the International Labour Organization, Having been convened at Geneva by the Governing Body of the I Influenza, COVID, RSV, many other viruses. Masks and hand hygiene. Cleaning of surfaces with dilute bleach. Not coming to work when unwell and symptomatic. MRO = multi-resistant organisms. Same as MDR (multi-drug resistance). DATE. PLACE. Disclaimer: This presentation contains information on the general principles for safe handling of hazardous drugs. This presentation cannot account for individual variation among facilities and cannot be considered inclusive of all proper methods of occupational safety. It is the responsibility of the facility management and staff to determine the best course of occupational safety for operations. The American Cancer Society and its partners assume no responsibility for any injury or damage to persons or property arising out of or related to any use of these materials, or for any errors or omissions. Last updated: February 2020. Exposure: Leg pain on walking, outcome: knee pain. Exposure: knee pain, outcome: . M15 . Polyarthrosis. Exposure: . M15 . Polyarthrosis. . , outcome: knee pain. Exposure: knee pain, outcome: . other specific joint derangements.